Screener
Biohaven BHVN Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | As of March 31, 2026 | As of December 31, 2025 |
|---|---|---|
| Accrued employee compensation and benefits | $4,428 | $16,781 |
| Accrued clinical trial costs | 21,541 | 30,437 |
| Operating lease liabilities - current portion | 5,900 | 5,756 |
| 2025 Additional Consideration True-Up liability | — | 42,710 |
| Other accrued expenses and other current liabilities | 9,784 | 8,607 |
| Accrued expenses and other current liabilities | $41,653 | $104,291 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's accrued expenses?
- Biohaven (BHVN) reported accrued expenses of $4.43M in Q1 2026.
- How has Biohaven's accrued expenses changed year-over-year?
- Biohaven's accrued expenses decreased by 32.1% year-over-year, from $6.53M to $4.43M.
- What is the long-term trend for Biohaven's accrued expenses?
- Over 4 years (2021 to 2025), Biohaven's accrued expenses has grown at a -18.0% compound annual growth rate (CAGR), from $37.16M to $16.78M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Biohaven's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude